Context Novel therapies have improved the remission rate in chronic inflammatory disorders
including juvenile idiopathic arthritis (JIA). Therefore, strategies of tapering therapy and …

Objective The current treatment options for systemic‐onset juvenile idiopathic arthritis (JIA)
are methotrexate, steroids, and biologic agents. This study was undertaken to evaluate the …

To develop evidence based points to consider the use of imaging in the diagnosis and
management of juvenile idiopathic arthritis (JIA) in clinical practice. The task force comprised a …

Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…

Objective To investigate the efficacy and safety of etanercept (ETN) in paediatric subjects
with extended oligoarticular juvenile idiopathic arthritis (eoJIA), enthesitis-related arthritis (ERA)…

Rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) are heterogeneous autoimmune
diseases characterized by chronic joint inflammation. Methotrexate is used as the gold …

Objective Musculoskeletal ultrasonography (US) has the potential to be an important tool in
the assessment of disease activity in childhood arthritides. To assess pathology, clear …

Objective The Outcome Measures in Rheumatology Ultrasound Task Force has recently
started to work on the validation and standardization of musculoskeletal ultrasound (MSUS) …

… Nasonov, 9, B Tonu Peets, 10, B Sonja Praprotnik, 11, B Rasho Rashkov, 12, B Jana
Skoupa, 13, B Witold Tlustochowicz, 14, B Malgorzata Tlustochowicz, 14, B Matija Tomsic …

Objective. The main objective was to determine the 2-year clinical benefit and safety of
etanercept (ETN) in children with the juvenile idiopathic arthritis (JIA) categories of extended …